Our Commitment to Our Customers and Partners

Dear Customers and Partners,

We recognize with the constantly changing COVID-19 situation that this is an unprecedented time in which you are facing tremendous challenges. In particular, we understand the seriousness of the work being done and the task ahead for our healthcare provider customers as you respond to this public health emergency.

I want you to know that we are committed to continuing to provide you with the information and services that you depend on from FDB. For more than 40 years, we have focused on our mission of creating a healthier world through the power of medical knowledge. This mission guides us closely as we continue to monitor, assess and respond to this situation.

We have implemented remote workplace policies contained within our Business Continuity Plan, and are operating on a 100% remote basis to ensure the safety of our employees and the ability to conduct our ongoing operations. If you would like to learn more information about this plan, please email cs@fdbhealth.com. Rest assured, we are prepared to continue to serve you.

We are adding into FDB MedKnowledge® information about medications being evaluated for treatment of COVID-19, including medications already approved by the FDA and those in investigational status. We are also adding information to our Patient Education and Specialty Pharmacy modules as appropriate. And we are in communication with the CDC about the potential to add information about investigational vaccines for COVID-19. All of this information will be made available to you for no additional charge.

We are taking these measures to ensure the health and safety of our employees, to limit the potential spread of the virus, and to ensure we can continue to provide you with the vital information you need. Our leadership team remains vigilant and is monitoring the situation in real time, and we are responding rapidly as conditions evolve.

Please stay safe and be healthy,

Bob Katter

Bob Katter

FDB President